Cargando…

Increased Leishmania infantum resistance to miltefosine and amphotericin B after treatment of a dog with miltefosine and allopurinol

BACKGROUND: Leishmania infantum is the most important etiological agent of visceral leishmaniasis in the Americas and Mediterranean region, and the dog is the main host. Miltefosine was authorized to treat canine leishmaniasis (CanL) in Brazil in 2017, but there is a persistent fear of the emergence...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gonçalves, Gustavo, Campos, Monique Paiva, Gonçalves, Alessandra Silva, Medeiros, Lia Carolina Soares, Figueiredo, Fabiano Borges
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656069/ https://www.ncbi.nlm.nih.gov/pubmed/34886876 http://dx.doi.org/10.1186/s13071-021-05100-x

Ejemplares similares

Resolution of tongue lesions caused by Leishmania infantum in a dog treated with the association miltefosine-allopurinol
por: Foglia Manzillo, Valentina, et al.
Publicado: (2009)

Mitochondrial Proteomics of Antimony and Miltefosine Resistant Leishmania infantum
por: Vincent, Isabel M., et al.
Publicado: (2015)

Miltefosine enhances infectivity of a miltefosine-resistant Leishmania infantum strain by attenuating its innate immune recognition
por: Bulté, Dimitri, et al.
Publicado: (2021)

New insights with miltefosine unresponsiveness in Brazilian Leishmania infantum isolates
por: Bhattacharya, Arijit, et al.
Publicado: (2018)

Use of miltefosine to treat canine visceral leishmaniasis caused by Leishmania infantum in Brazil
por: dos Santos Nogueira, Fabio, et al.
Publicado: (2019)

In-Depth Quantitative Proteomics Characterization of In Vitro Selected Miltefosine Resistance in Leishmania infantum
por: Saboia-Vahia, Leonardo, et al.
Publicado: (2022)

3′Nucleotidase/nuclease is required for Leishmania infantum clinical isolate susceptibility to miltefosine
por: Carnielli, Juliana B.T., et al.
Publicado: (2022)

Effect of Clindamycin on Intestinal Microbiome and Miltefosine Pharmacology in Hamsters Infected with Leishmania infantum
por: Olías-Molero, Ana Isabel, et al.
Publicado: (2023)

Proteinuria reduction after treatment with miltefosine and allopurinol in dogs naturally infected with leishmaniasis
por: Proverbio, Daniela, et al.
Publicado: (2016)

Clinical and Laboratory Response of Domiciled Dogs with Visceral Leishmaniasis Treated with Miltefosine and Allopurinol
por: Vaz, Talita Pereira, et al.
Publicado: (2023)

Pharmacodynamics and cellular accumulation of amphotericin B and miltefosine in Leishmania donovani-infected primary macrophages
por: Voak, Andrew A, et al.
Publicado: (2018)

Miltefosine-Lopinavir Combination Therapy Against Leishmania infantum Infection: In vitro and in vivo Approaches
por: Rebello, Karina M., et al.
Publicado: (2019)

A Leishmania infantum genetic marker associated with miltefosine treatment failure for visceral leishmaniasis
por: Carnielli, Juliana B.T., et al.
Publicado: (2018)

Combined treatment of miltefosine and paromomycin delays the onset of experimental drug resistance in Leishmania infantum
por: Hendrickx, Sarah, et al.
Publicado: (2017)

Impact of clinically acquired miltefosine resistance by Leishmania infantum on mouse and sand fly infection
por: Van Bockstal, Lieselotte, et al.
Publicado: (2020)

Long-term follow-up of dogs with leishmaniosis treated with meglumine antimoniate plus allopurinol versus miltefosine plus allopurinol
por: Manna, Laura, et al.
Publicado: (2015)

Untargeted metabolomic analysis of miltefosine action in Leishmania infantum reveals changes to the internal lipid metabolism()
por: Vincent, Isabel M., et al.
Publicado: (2013)

Natural Resistance of Leishmania infantum to Miltefosine Contributes to the Low Efficacy in the Treatment of Visceral Leishmaniasis in Brazil
por: Carnielli, Juliana B. T., et al.
Publicado: (2019)

Downregulation of FeSOD-A expression in Leishmania infantum alters trivalent antimony and miltefosine susceptibility
por: Santi, Ana Maria Murta, et al.
Publicado: (2021)

Retrospective Long-Term Evaluation of Miltefosine-Allopurinol Treatment in Canine Leishmaniosis
por: Gizzarelli, Manuela, et al.
Publicado: (2023)

Leishmania Resistance to Miltefosine Associated with Genetic Marker
por: Cojean, Sandrine, et al.
Publicado: (2012)

Unravelling the rate of action of hits in the Leishmania donovani box using standard drugs amphotericin B and miltefosine
por: Tegazzini, Diana, et al.
Publicado: (2017)

Generation of Luciferase-Expressing Leishmania infantum chagasi and Assessment of Miltefosine Efficacy in Infected Hamsters through Bioimaging
por: Reimão, Juliana Q., et al.
Publicado: (2015)

A case of canine visceral leishmaniasis of unknown origin in Curitiba (state of Paraná, Brazil) treated successfully with miltefosine
por: Gonçalves, Gustavo, et al.
Publicado: (2023)

Fitness and Phenotypic Characterization of Miltefosine-Resistant Leishmania major
por: Turner, Kimbra G., et al.
Publicado: (2015)

Complex cutaneous infection by Leishmania mexicana treated with miltefosine
por: Sadowsky, Rachel L., et al.
Publicado: (2022)

Immunosuppression of Syrian golden hamsters accelerates relapse but not the emergence of resistance in Leishmania infantum following recurrent miltefosine pressure
por: Hendrickx, S., et al.
Publicado: (2018)

In Vitro Susceptibility to Miltefosine of Leishmania infantum (syn. L. chagasi) Isolates from Different Geographical Areas in Brazil
por: Espada, Caroline Ricce, et al.
Publicado: (2021)

Evaluation of a Possible Synergistic Effect of Meglumine Antimoniate with Paromomycin, Miltefosine or Allopurinol on in Vitro Susceptibility of Leishmania tropica Resistant Isolate
por: REZAEI RIABI, Tahereh, et al.
Publicado: (2013)

Pharmacokinetic / pharmacodynamic relationships of liposomal amphotericin B and miltefosine in experimental visceral leishmaniasis
por: Voak, Andrew A., et al.
Publicado: (2021)

Impaired development of a miltefosine-resistant Leishmania infantum strain in the sand fly vectors Phlebotomus perniciosus and Lutzomyia longipalpis
por: Van Bockstal, Lieselotte, et al.
Publicado: (2019)

No evidence for cardiotoxicity of miltefosine()
por: Dorlo, Thomas P.C.
Publicado: (2022)

Allopurinol Resistance in Leishmania infantum from Dogs with Disease Relapse
por: Yasur-Landau, Daniel, et al.
Publicado: (2016)

Induction of allopurinol resistance in Leishmania infantum isolated from dogs
por: Yasur-Landau, Daniel, et al.
Publicado: (2017)

In vitro anti-Leishmania activity of triclabendazole and its synergic effect with amphotericin B
por: Borges, Beatriz Santana, et al.
Publicado: (2023)

Comparison of Two Dosing Regimens of Miltefosine, Both in Combination With Allopurinol, on Clinical and Parasitological Findings of Dogs With Leishmaniosis: A Pilot Study
por: Iarussi, Fabrizio, et al.
Publicado: (2020)

No evidence for cardiotoxicity of miltefosine – Reply()
por: Barroso, Daniel Holanda, et al.
Publicado: (2022)

Genomic and Molecular Characterization of Miltefosine Resistance in Leishmania infantum Strains with Either Natural or Acquired Resistance through Experimental Selection of Intracellular Amastigotes
por: Mondelaers, Annelies, et al.
Publicado: (2016)

Miltefosine-Induced Apoptotic Cell Death on Leishmania major and L. tropica Strains
por: Khademvatan, Shahram, et al.
Publicado: (2011)

Serosurvey of anti-Leishmania (Leishmania) infantum antibodies in hunting dogs and hunters in Brazil
por: Kmetiuk, Louise Bach, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u4i3j0pahc1ljq8scgko5cjqbk